About
ZalVac develops vaccines based on bacterial membrane vesicles to induce immunity against multiple bacterial strains, leveraging academic research by Birgitta Henriques Normark and Staffan Normark.
Explore ZalVac's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.